D-0423-2018 Class II Terminated

Recalled by PharMEDium Services, LLC — Dayton, NJ

FDA drug recall D-0423-2018 was initiated by PharMEDium Services, LLC on Feb 5, 2018 and is designated Class II. Reason for recall: Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin. The recall status is terminated (terminated Apr 24, 2018). Affected quantity: 21 Cassettes.

Recall Details

Product Type
Drugs
Report Date
Feb 21, 2018
Initiation Date
Feb 5, 2018
Termination Date
Apr 24, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
21 Cassettes

Product Description

0.2% Ropivacaine HCI (Preservative Free) in 0.9 Sodium Chloride, Epidural, 250 mL Yellow Cassette, Rx only, PharMEDium Serivces, LLC

Reason for Recall

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

Distribution Pattern

Product was distributed to SC, FL, NY, NY,WA

Code Information

Lot #: 180030029D, Exp 2/18/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0423-2018
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.